Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-man Clinical Trial to Assess Safety and Tolerability of CEB-01 PLGA Membrane in Patients With Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma After Surgery

NCT04619056 is registered in ClinicalTrials.gov with CEBIOTEX as lead sponsor.

NCT NCT04619056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04619056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-man Clinical Trial to Assess Safety and Tolerability of CEB-01 PLGA Membrane in Patients With Recurrent or Locally Advanced Retroperitoneal Soft Tissue Sarcoma After Surgery
Lead sponsor
CEBIOTEX
Phase
Phase 1
Overall status
Completed
Start date
June 3, 2020
Completion date
November 28, 2025
Enrollment
21 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced soft tissue sarcoma, recurrent soft tissue sarcoma